Chapter 11: Artificial Intelligence in Cardiovascular Medicine
1.Scope & Potential
AI and ML are being applied across cardiology—heart failure, electrophysiology, valvular disease, coronary artery disease—to automate complex data analysis and improve diagnostic, predictive, and workflow efficiency.
2.Automation & Deep Phenotyping
AI excels at analyzing massive datasets like continuous ECG or imaging to unearth subtle signals—e.g., identifying left ventricular dysfunction from 12‑lead ECG, real-time arrhythmia detection, and deep phenotyping of preclinical disease.
3.Clinical Applications
•Heart failure: automated echocardiographic segmentation tools (e.g. HeartModel A.I.) track ventricular volumes and function with high reproducibility.
•ECG & outcomes: Deep learning models can detect myocardial infarction, predict adverse events post‑acute coronary syndrome, and stratify risk.
4.Challenges & Validation Needs
Barriers include lack of large multicenter validation, algorithmic bias, data privacy concerns, regulatory oversight and integration into clinical workflows.
5.Future Directions
Integration of multimodal data (imaging, EHR, wearables), adaptive learning models, prospective trials, and closer collaboration between clinicians, data scientists, and regulators.
1.应用领域与潜力
AI/机器学习在心衰、电生理、瓣膜病和冠状动脉疾病中广泛应用,可自动分析复杂数据,提升诊断准确性、预后预测能力与工作流程效率。
2.自动化与深度表型识别
AI 能分析海量连续 ECG 或影像数据,识别诸如从标准 12 导联 ECG 推断左室功能、实时心律失常检测、以及临床前疾病的深度表型。
3.临床应用实例
•心衰: HeartModel A.I. 等工具可自动进行 3D 超声心室体积与功能分析,结果高度可靠。
•心电图与预后:深度学习模型可用于自动识别心肌梗死、预测 ACS 后不良事件、进行风险分层。
4.面临挑战与验证需求
包括缺乏大规模、多中心前瞻性验证;算法偏见与公平性问题;数据隐私与监管;如何融入临床流程尚待解决。
5.未来发展趋势
跨模态数据整合(影像、电子病历、穿戴设备)、自适应学习模型、前瞻试验,以及临床专家与数据科学家、监管机构的密切合作。
—《Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine》